COMP <GO>
EW vs ISRG // ALTMAN Z-SCORE & DEBT/EQUITY
Edwards Lifesciences Corporation (NYSE) VS. Intuitive Surgical Inc. (NASDAQ) • 15-METRIC TALLY: EW 5
— ISRG 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: ISRG
LAST: $92.01 (-2.57%) • MKT CAP: $54.44B
balance-sheet
12.36
LAST: $432.01 (-3.73%) • MKT CAP: $155.56B
balance-sheet
26.00
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EW VS. ISRG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EW | ISRG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 78.00% | 66.00% | +12.00 | EW | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.50% | 15.00% | -2.50 | ISRG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 35.1x | 46.0x | -10.90 | EW | /valuation <GO> |
| Free Cash Flow Yield | 2.45% | 1.66% | +0.79 | EW | /fcf-yield <GO> |
| Operating Margin | 20.80% | 29.30% | -8.50 | ISRG | /operating-margins <GO> |
| Net Profit Margin | 17.70% | 28.40% | -10.70 | ISRG | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 20.50% | -9.00 | ISRG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 12.36 | 26.00 | -13.64 | ISRG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | ISRG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.1 | 61.7 | +3.40 | EW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.97 | +0.11 | EW | /macro-sensitivity <GO> |
| Forward P/E Multiple | 47.2x | 45.8x | +1.40 | ISRG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $54.44B | $155.56B | -$101.12B | ISRG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EW REV | ISRG REV | EW GROSS % | ISRG GROSS % | EW FCF | ISRG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.07B | $10.06B | 78.0% | 66.0% | $1.33B | $2.58B |
| FY 2024 | $5.44B | $8.35B | 79.5% | 67.5% | $289.9M | $2.04B |
| FY 2023 | $5.01B | $7.12B | — | — | $670.4M | $1.49B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EW // BETA 1.08
ISRG // BETA 0.97